ACA
APVO icon

Atlas Capital Advisors’s Aptevo Therapeutics APVO Stock Holding History

Atlas Capital Advisors’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Hold
0
– -$19.1K – 331
2020
Q2 		– Hold
0
– – – 554
2020
Q1 		– Hold
0
– – – 592
2019
Q4 		– Hold
0
– – – 502
2019
Q3 		– Hold
0
– – – 500
2019
Q2 		– Hold
0
– – – 488
2019
Q1 		– Hold
0
– – – 430
2018
Q4 		– Hold
0
– – – 391
2018
Q3 		– Hold
0
– – – 276
2018
Q2 		– Hold
0
– – – 250
2018
Q1 		– Hold
0
– – – 310

Other funds holding APVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return